• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Lifshitz Law PLLC Announces Investigations of BG, KDNY, QUOT, and DICE

    6/24/23 8:11:00 PM ET
    $BG
    $DICE
    $KDNY
    $QUOT
    Packaged Foods
    Consumer Staples
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $BG alert in real time by email

    NEW YORK, June 24, 2023 (GLOBE NEWSWIRE) --

    Bunge Limited (NYSE:BG)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of BG and Viterra Limited. Under the terms of the agreement, Viterra Limited shareholders will receive approximately 65.6 million shares of BG common stock and $2.0 billion in cash. In addition, BG will assume $9.8 billion of Viterra Limited debt and BG plans to repurchase $2.0 billion of BG common stock.

    If you are a BG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    Chinook Therapeutics, Inc. (NASDAQ:KDNY)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of KDNY to Novartis AG for $40.00 per share in cash, plus a CVR of up to $4.00 per share payable upon the achievement of certain future regulatory milestones with respect to its lead product candidate, atrasentan.

    If you are a KDNY investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    Quotient Technology, Inc. (NYSE:QUOT)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of QUOT to Neptune Retail Solutions for $4.00 per share in cash.

    If you are a QUOT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    DICE Therapeutics, Inc. (NASDAQ:DICE)

    Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of DICE to Eli Lilly & Co. for $48.00 per share in cash.

    If you are a DICE investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

    ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

    Contact:

    Joshua M. Lifshitz, Esq.

    Lifshitz Law PLLC

    Phone: 516-493-9780

    Facsimile: 516-280-7376

    Email: [email protected]



    Get the next $BG alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BG
    $DICE
    $KDNY
    $QUOT

    CompanyDatePrice TargetRatingAnalyst
    Bunge Limited
    $BG
    8/20/2025$95.00Overweight
    Analyst
    Bunge Limited
    $BG
    1/21/2025$115.00 → $95.00Overweight → Equal Weight
    Barclays
    Bunge Limited
    $BG
    8/1/2024$125.00 → $114.00Buy → Neutral
    Citigroup
    Bunge Limited
    $BG
    2/9/2024$122.00 → $105.00Hold → Buy
    HSBC Securities
    Bunge Limited
    $BG
    2/1/2024$108.00Buy
    Citigroup
    Bunge Limited
    $BG
    1/10/2024Outperform → Peer Perform
    Wolfe Research
    Bunge Limited
    $BG
    9/15/2023$122.00Hold
    HSBC Securities
    Chinook Therapeutics Inc.
    $KDNY
    8/8/2023$42.00Outperform → Neutral
    Wedbush
    More analyst ratings

    $BG
    $DICE
    $KDNY
    $QUOT
    SEC Filings

    View All

    SEC Form 10-Q filed by Bunge Limited

    10-Q - Bunge Global SA (0001996862) (Filer)

    8/5/25 9:15:42 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge Limited filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Bunge Global SA (0001996862) (Filer)

    8/4/25 4:46:24 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    SEC Form FWP filed by Bunge Limited

    FWP - Bunge Global SA (0001996862) (Subject)

    7/31/25 5:28:17 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    $BG
    $DICE
    $KDNY
    $QUOT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Bunge with a new price target

    Analyst resumed coverage of Bunge with a rating of Overweight and set a new price target of $95.00

    8/20/25 8:33:18 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge downgraded by Barclays with a new price target

    Barclays downgraded Bunge from Overweight to Equal Weight and set a new price target of $95.00 from $115.00 previously

    1/21/25 7:41:13 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge downgraded by Citigroup with a new price target

    Citigroup downgraded Bunge from Buy to Neutral and set a new price target of $114.00 from $125.00 previously

    8/1/24 6:22:03 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    $BG
    $DICE
    $KDNY
    $QUOT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Bunge Global SA Announces Pricing of $1.3 Billion Senior Notes Offering

    Bunge Global SA (NYSE:BG) (the "Company" or "Bunge") today announced that Bunge Limited Finance Corp., its wholly owned finance subsidiary, has successfully priced a public offering of $1.3 billion aggregate principal amount, comprised of two tranches of senior unsecured notes (collectively, the "Senior Notes"), as follows: $650 million aggregate principal amount of 4.550% Senior Notes due 2030 (the "2030 Notes"); and $650 million aggregate principal amount of 5.150% Senior Notes due 2035 (the "2035 Notes"). The Senior Notes will be fully and unconditionally guaranteed by Bunge Global SA on a senior unsecured basis. The offering was made pursuant to a registration statement filed w

    7/31/25 6:45:00 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge Reports Second Quarter 2025 Results

    Bunge Global SA (NYSE:BG) today reported second quarter 2025 results This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730824304/en/Bunge Reports Second Quarter 2025 Results Q2 GAAP diluted EPS of $2.61 vs. $0.48 in the prior year; $1.31 vs. $1.73 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Agribusiness results better than expected driven by Processing, though down from last year Refined and Specialty Oils results reflected lower energy demand due to policy uncertainty Recently completed merger with Viterra to create premier global agribusiness solutions company; integrati

    7/30/25 6:00:00 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge Schedules Second Quarter 2025 Earnings Release and Conference Call

    Bunge Global SA (NYSE:BG) will announce its results for the quarter ended June 30, 2025, on Wednesday, July 30, 2025, prior to the market opening. The Company's management will also host a conference call at 7 a.m. Central Time to discuss the results. A slide presentation to accompany the discussion will be posted at www.bunge.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709812855/en/BG) will announce its results for the quarter ended June 30, 2025, on Wednesday, July 30, 2025, prior to the market opening.">Bunge Global SA (NYSE:BG) will announce its results for the quarter ended June 30, 2025, on Wednesday, July 30, 2

    7/9/25 7:00:00 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    $BG
    $DICE
    $KDNY
    $QUOT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mahoney Christopher bought $408,650 worth of shares (5,000 units at $81.73), increasing direct ownership by 231% to 7,164 units (SEC Form 4)

    4 - Bunge Global SA (0001996862) (Issuer)

    8/20/25 6:37:27 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    $BG
    $DICE
    $KDNY
    $QUOT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mahoney Christopher bought $408,650 worth of shares (5,000 units at $81.73), increasing direct ownership by 231% to 7,164 units (SEC Form 4)

    4 - Bunge Global SA (0001996862) (Issuer)

    8/20/25 6:37:27 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    Co-Chief Operating Officer Mattiske David was granted 95,017 shares, increasing direct ownership by 168% to 151,486 units (SEC Form 4)

    4 - Bunge Global SA (0001996862) (Issuer)

    7/17/25 4:52:03 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    New insider Canada Pension Plan Investment Board claimed ownership of 26,244,732 units of Registered Shares (SEC Form 3)

    3 - Bunge Global SA (0001996862) (Issuer)

    7/8/25 5:48:07 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    $BG
    $DICE
    $KDNY
    $QUOT
    Financials

    Live finance-specific insights

    View All

    Bunge Reports Second Quarter 2025 Results

    Bunge Global SA (NYSE:BG) today reported second quarter 2025 results This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730824304/en/Bunge Reports Second Quarter 2025 Results Q2 GAAP diluted EPS of $2.61 vs. $0.48 in the prior year; $1.31 vs. $1.73 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Agribusiness results better than expected driven by Processing, though down from last year Refined and Specialty Oils results reflected lower energy demand due to policy uncertainty Recently completed merger with Viterra to create premier global agribusiness solutions company; integrati

    7/30/25 6:00:00 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge Schedules Second Quarter 2025 Earnings Release and Conference Call

    Bunge Global SA (NYSE:BG) will announce its results for the quarter ended June 30, 2025, on Wednesday, July 30, 2025, prior to the market opening. The Company's management will also host a conference call at 7 a.m. Central Time to discuss the results. A slide presentation to accompany the discussion will be posted at www.bunge.com. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250709812855/en/BG) will announce its results for the quarter ended June 30, 2025, on Wednesday, July 30, 2025, prior to the market opening.">Bunge Global SA (NYSE:BG) will announce its results for the quarter ended June 30, 2025, on Wednesday, July 30, 2

    7/9/25 7:00:00 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    Bunge Reports First Quarter 2025 Results

    Bunge Global SA (NYSE:BG) today reported first quarter 2025 results Q1 GAAP diluted EPS of $1.48 vs. $1.68 in the prior year; $1.81 vs. $3.04 on an adjusted basis excluding certain gains/charges and mark-to-market timing differences Solid performance in Agribusiness driven by Processing, though down from last year Refined and Specialty Oils results reflected a more balanced supply and demand environment, particularly in the U.S. In final stage of regulatory process for Viterra transaction Further strengthened business alignment with our global value chains through agreements to divest regional corn milling and margarine businesses Maintaining adjusted full-year EPS outlook of ap

    5/7/25 6:00:00 AM ET
    $BG
    Packaged Foods
    Consumer Staples

    $BG
    $DICE
    $KDNY
    $QUOT
    Leadership Updates

    Live Leadership Updates

    View All

    Bunge Announces Approval of Quarterly Dividends and Changes to Board of Directors by Shareholders at 2025 Annual General Meeting

    Shareholders of Bunge Global SA (NYSE:BG) approved a cash dividend in the amount of $2.80 per share, payable in four equal installments of $0.70, at the company's 2025 Annual General Meeting held in Switzerland today ("AGM"). The dividends will be paid as indicated below: Bunge Quarter, Fiscal Year Payment Date Record Date Amount 2nd Quarter, Fiscal Year 2025 June 2, 2025 May 19, 2025 $0.70 3rd Quarter, Fiscal Year 2025 September 2, 2025 August 19, 2025 $0.70 4th Quarter, Fiscal Year 2025 December 1, 2025 November 17, 2025 $0.70 1st Quarter, Fiscal Year 2026 March 3, 2026 February 17, 2026 $0.70 Shareholders also approv

    5/15/25 5:00:00 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    Chinook Therapeutics Reports First Quarter 2023 Financial Results and Provides Corporate Updates

    SEATTLE, May 09, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ:KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today reported financial results for the first quarter ended March 31, 2023 and provided corporate updates. "During the first quarter of 2023, we continued to advance our pipeline of clinical and preclinical programs for rare, severe chronic kidney diseases. We recently completed full enrollment of the phase 3 ALIGN clinical trial, are on track to initiate the phase 3 BION-1301 IgAN clinical trial mid-year and expect to report topline ALIGN results in the fourth quarter of thi

    5/9/23 4:00:00 PM ET
    $KDNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors

    SEATTLE, April 13, 2023 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ:KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced the appointment of Robert W. Azelby to its Board of Directors. Mr. Azelby brings more than 20 years of executive leadership and commercial experience in the biopharmaceutical industry to Chinook. "We are thrilled to welcome Bob to Chinook's board of directors as we advance our pipeline through key milestones in 2023 and beyond," said Eric Dobmeier, president and chief executive officer of Chinook Therapeutics. "Bob brings significant industry experience in bu

    4/13/23 8:00:00 AM ET
    $KDNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BG
    $DICE
    $KDNY
    $QUOT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Bunge Limited

    SC 13G/A - Bunge Global SA (0001996862) (Subject)

    11/7/24 12:58:26 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    Amendment: SEC Form SC 13G/A filed by Bunge Limited

    SC 13G/A - Bunge Global SA (0001996862) (Subject)

    11/6/24 2:13:04 PM ET
    $BG
    Packaged Foods
    Consumer Staples

    SEC Form SC 13G/A filed by Bunge Limited (Amendment)

    SC 13G/A - Bunge Global SA (0001996862) (Subject)

    3/7/24 12:29:51 PM ET
    $BG
    Packaged Foods
    Consumer Staples